| Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma (NCT04674683) | HUYABIO International, LLC. | 2021-08-12 |
| EPI-MINN: Targeting Cognition and Motivation (NCT05112432) | University of Minnesota | 2021-08-12 |
| Rapamycin - Effects on Alzheimer's and Cognitive Health (NCT04629495) | The University of Texas Health Science Center at San Antonio | 2021-08-11 |
| Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations (NCT04923906) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-08-11 |
| SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs (NCT04710563) | Yale University | 2021-08-11 |
| 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer (NCT04663997) | Canadian Cancer Trials Group | 2021-08-11 |
| A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy (NCT05072288) | Université du Québec à Chicoutimi | 2021-08-11 |
| Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis (NCT04951986) | University of Cape Town | 2021-08-11 |
| BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions (NCT04830228) | Biotronik AG | 2021-08-10 |
| A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma (NCT04897022) | Memorial Sloan Kettering Cancer Center | 2021-08-10 |
| Post Acute Sequelae of COVID-19 (NCT04964115) | Vanderbilt University Medical Center | 2021-08-10 |
| The COlchicine HypERtENsion Trial (NCT04916522) | Herlev and Gentofte Hospital | 2021-08-10 |
| Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer (NCT05055843) | M.D. Anderson Cancer Center | 2021-08-10 |
| Neurophysiological RCT of Qigong in Elderly With Depression (NCT05000788) | The Hong Kong Polytechnic University | 2021-08-09 |
| Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis (NCT04749667) | Haukeland University Hospital | 2021-08-09 |
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661) | National Cancer Institute (NCI) | 2021-08-09 |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04377932) | Baylor College of Medicine | 2021-08-08 |
| Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (NCT04643379) | Washington University School of Medicine | 2021-08-07 |
| US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair (NCT04852783) | Cerus Endovascular, Inc. | 2021-08-06 |
| EUS Glue vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With HCC and EV Bleeding: a Retrospective Comparative Study (NCT04918459) | Chinese University of Hong Kong | 2021-08-06 |
| A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia (NCT04899661) | Bayer | 2021-08-06 |
| Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading (NCT05003817) | Guy's and St Thomas' NHS Foundation Trust | 2021-08-06 |
| Ocular Comorbidity in Atopic Dermatitis (NCT04973384) | Rigshospitalet, Denmark | 2021-08-05 |
| OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC (NCT04713514) | ARCAGY/ GINECO GROUP | 2021-08-05 |
| Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86) (NCT04956692) | Merck Sharp & Dohme LLC | 2021-08-05 |
| Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) (NCT04967807) | University Health Network, Toronto | 2021-08-05 |
| Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer (NCT04733118) | MedSIR | 2021-08-05 |
| Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent (NCT05050591) | VisionAir Solutions | 2021-08-05 |
| Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (NCT04960709) | AstraZeneca | 2021-08-05 |
| Dispersion Stability (NCT04945746) | Hospital St. Joseph, Marseille, France | 2021-08-05 |
| Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases (NCT04640142) | Octapharma | 2021-08-04 |
| A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer (NCT04997018) | Memorial Sloan Kettering Cancer Center | 2021-08-04 |
| Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients (NCT04998877) | Johns Hopkins University | 2021-08-04 |
| Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC (NCT04497584) | University of Texas Southwestern Medical Center | 2021-08-04 |
| A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors (NCT04913285) | Pierre Fabre Medicament | 2021-08-04 |
| AIRB-4: Self-Determined Learning Model of Instruction (NCT04972851) | Health Resources and Services Administration (HRSA) | 2021-08-04 |
| Axitinib + Ipilimumab in Advanced Melanoma (NCT04996823) | H. Lee Moffitt Cancer Center and Research Institute | 2021-08-04 |
| Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer (NCT04791839) | Washington University School of Medicine | 2021-08-04 |
| Pulmonary Embolism International THrOmbolysis Study-3 (NCT04430569) | Assistance Publique - Hôpitaux de Paris | 2021-08-04 |
| Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project) (NCT04921644) | German Cancer Research Center | 2021-08-04 |
| Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma (NCT04626791) | Academic and Community Cancer Research United | 2021-08-03 |
| Combination Immunotherapy in Rare Cancers Under InvesTigation (NCT04969887) | Olivia Newton-John Cancer Research Institute | 2021-08-03 |
| CREATE Trial, Prospective, Observational Study (NCT05658250) | Yonsei University | 2021-08-03 |
| Diabetes Medical Nutrition Therapy in Southeastern African American Women (NCT04971889) | Meharry Medical College | 2021-08-03 |
| Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia (NCT04276155) | Centre Hospitalier de PAU | 2021-08-03 |
| Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer (NCT04605731) | City of Hope Medical Center | 2021-08-03 |
| Preventing Recurrent Cardioembolic Stroke (The PRECISE Study) (NCT06767189) | University of Glasgow | 2021-08-03 |
| Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma. (NCT05097911) | National University Hospital, Singapore | 2021-08-02 |
| Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism (NCT04790370) | Boston Scientific Corporation | 2021-08-02 |
| Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells (NCT03690011) | Baylor College of Medicine | 2021-08-02 |
| Management of CSDH With or Without EMMA- a Randomized Control Trial (NCT04750200) | University of Manitoba | 2021-08-01 |
| Statin-Intolerance Registry (NCT04975594) | University of Leipzig | 2021-08-01 |
| Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities (NCT05449418) | Kaiser Permanente | 2021-08-01 |
| A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD (NCT04691154) | Liquidia Technologies, Inc. | 2021-08-01 |
| PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma (NCT04907370) | Sun Yat-sen University | 2021-08-01 |
| Effects of Complementary Feeding on Infant Growth and Gut Health (NCT05012930) | University of Colorado, Denver | 2021-08-01 |
| The CROCO Study: CROhn's Disease COhort Study (NCT05420233) | GLSMED Learning Health S.A. | 2021-08-01 |
| A Novel Computer-Based Functional Skills Assessment and Training Program (NCT04679441) | i-Function, Inc. | 2021-08-01 |
| Effects of Virtual Reality and Breathing Exercises on Hemodialysis Patients' Symptoms and Quality of Life (NCT06968130) | Trakya University | 2021-08-01 |
| PMCF Study in Patients With Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated With E-vita OPEN NEO (NCT04986709) | JOTEC GmbH | 2021-08-01 |
| ARMOR-Household: Characterizing Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases (NCT05467917) | Columbia University | 2021-08-01 |
| Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis (NCT05001984) | Chang Gung Memorial Hospital | 2021-08-01 |
| Open Trial of Biofeedback for Respiratory Symptoms (NCT05973513) | University of California, Los Angeles | 2021-08-01 |
| Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension (NCT04938167) | University of California, Davis | 2021-08-01 |
| MIRACLE of LIFE Study (NCT06074601) | Mirvie | 2021-08-01 |
| MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women (NCT03586414) | University of Colorado, Denver | 2021-08-01 |
| Implementation and Assessment of the BE-FIT Program (NCT05338528) | University of Alberta | 2021-08-01 |
| 8-day Intensive Treatment Programme for PTSD and CPTSD in Sweden (NCT06645028) | Christina Blomdahl | 2021-08-01 |
| Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (NCT05220917) | Brigham and Women's Hospital | 2021-08-01 |
| Quality of Life Improvement During Chemotherapy (NCT04694885) | University Hospital, Basel, Switzerland | 2021-07-31 |
| Effects of GRA in Patients With Type 1 (NCT04779645) | University of California, San Diego | 2021-07-31 |
| Rectocele Repair with or Without Internal Sphincter Botulinum Toxin Injection: a Prospective Randomized Trial (NCT06804993) | Mansoura University | 2021-07-31 |
| Improvement of Nutritional Status in Cancer Patients and Reduction of Malnutrition (NCT07018687) | Médipôle Lyon-Villeurbanne | 2021-07-30 |
| An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer (NCT06532344) | Ono Pharmaceutical Co., Ltd. | 2021-07-30 |
| The Medacta Quadra-P Anteverted Study (NCT05460715) | Medacta International SA | 2021-07-30 |
| Michigan Early Disease Progression Cohort (NCT04968249) | University of Michigan | 2021-07-30 |
| A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer (NCT05055323) | Thomas Jefferson University | 2021-07-29 |
| AIR-B4: Mind the Gap (NCT04972825) | Health Resources and Services Administration (HRSA) | 2021-07-29 |
| Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT04883242) | University of Washington | 2021-07-29 |
| CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old (NCT04269213) | Roswell Park Cancer Institute | 2021-07-29 |
| Improvement of Live Babies Rates After ICSI, Using cpFT (NCT04954274) | Assistance Publique - Hôpitaux de Paris | 2021-07-29 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM (NCT07217184) | GlaxoSmithKline | 2021-07-29 |
| A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions (NCT04914598) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2021-07-28 |
| Histamine as a Molecular Transducer of Adaptation to Exercise (NCT05206227) | University of Oregon | 2021-07-28 |
| China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (NCT06868654) | GlaxoSmithKline | 2021-07-28 |
| National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (NCT04145141) | National Cancer Institute (NCI) | 2021-07-28 |
| " SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients" (NCT04945785) | Nantes University Hospital | 2021-07-28 |
| Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (NCT06868667) | GlaxoSmithKline | 2021-07-28 |
| Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT04747613) | Novartis Pharmaceuticals | 2021-07-27 |
| Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma (NCT04635189) | University of Rochester | 2021-07-27 |
| A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04910568) | Genentech, Inc. | 2021-07-26 |
| M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study (NCT04982835) | Orthofix Inc. | 2021-07-26 |
| ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk (NCT05064553) | Exact Sciences Corporation | 2021-07-26 |
| Use of a Compression Device for Ring Removal: A Prospective Trial (NCT04728607) | Nova Scotia Health Authority | 2021-07-26 |
| Promoting HPV Vaccination Among Young Adults in Texas (NCT05057312) | M.D. Anderson Cancer Center | 2021-07-26 |
| A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China (NCT05009329) | Allist Pharmaceuticals, Inc. | 2021-07-26 |
| Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies (NCT04541108) | Presage Biosciences | 2021-07-26 |
| The Effect Of Virtual Reality Glasses On Pain And Anxiety During The Kidney Stone Lithotripsy Procedure (NCT06629727) | University of Beykent | 2021-07-25 |
| the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration (NCT05126446) | Lifetech Scientific (Shenzhen) Co., Ltd. | 2021-07-25 |
| Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977 (NCT04862286) | AbbVie | 2021-07-24 |